Systematic screening of Retinopathy in Diabetes (REaD project): An Italian implementation campaign

European Journal of Ophthalmology

Volumn 27, Issue 2, 2017, Pages 179-184

  Porta, Massimo ^a   Boscia, Francesco ^b   Lanzetta, Paolo ^c   Mannucci, Edoardo ^d   Menchini, Ugo ^d   Simonelli, Francesca ^e  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c UNIVERSITY OF UDINE   (Italy)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

^e SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Diabetic macular edema; Diabetic retinopathy; Screening; Teleophthalmology

Indexed keywords

ARTICLE; CLINICAL ARTICLE; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; FUNDUS CAMERA; HUMAN; HYPERTENSION; IMAGE QUALITY; ITALY; MALE; MYDRIASIS; PRIORITY JOURNAL; PUBLIC HEALTH CAMPAIGN; RETINOGRAPHY; SMOKING; TELEMEDICINE; ADOLESCENT; ADULT; AGED; CHILD; COMPLICATION; FLUORESCENCE ANGIOGRAPHY; HEALTH CARE PLANNING; HEALTH PROMOTION; INSULIN DEPENDENT DIABETES MELLITUS; MASS SCREENING; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ORGANIZATION AND MANAGEMENT; PRESCHOOL CHILD; VERY ELDERLY; VISUAL SYSTEM EXAMINATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; FEMALE; FLUORESCEIN ANGIOGRAPHY; HEALTH PLAN IMPLEMENTATION; HEALTH PROMOTION; HUMANS; ITALY; MALE; MASS SCREENING; MIDDLE AGED; TELEMEDICINE;

EID: 85015740070     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.5301/ejo.5000912     Document Type: Article

References (31)

1. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37(Suppl 1):S81-S90.
2. Yau JW, Rogers SL, Kawasaki R, et al; Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3): 556-564.
3. National Diabetes Fact Sheet. national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta: Department of Health and Human Services, Centers for Control and Prevention, 2011.
4. Fong DS, Aiello L, Gardner TW, et al; American Diabetes Association. Diabetic retinopathy. Diabetes Care. 2003;26(Suppl 1): S99-S102.
5. Klein BE. Overview of epidemiologic studies of diabetic retinopathy. Ophthalmic Epidemiol. 2007;14(4):179-183.
6. Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2014;2(2):CD009122.
7. Hemmingsen B, Lund SS, Gluud C, et al. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2013;11(11):CD008143.
8. American Diabetes Association. Standards of medical care in diabetes 2013. Diabetes Care. 2013;36(Suppl 1):S11-S66.
9. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology. 1978;85(1):82-106.
10. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Ophthalmology. 1991;98(5)(Suppl):766-785.
11. Guidelines for the Screening, Diagnosis and Treatment of Diabetic Retinopathy in Italy. Text revision - 2015. Available at: http://www.aemmedi.it/pages/linee-guida_e_raccomandazioni/.
12. Brown LC, Johnson JA, Majumdar SR, Tsuyuki RT, McAlister FA. Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. CMAJ. 2004;171(10):1189-1192.
13. Coon P, Zulkowski K. Adherence to American Diabetes Association standards of care by rural health care providers. Diabetes Care. 2002;25(12):2224-2229.
14. Zimmer-Galler IE, Kimura AE, Gupta S. Diabetic retinopathy screening and the use of telemedicine. Curr Opin Ophthalmol. 2015;26(3):167-172.
15. Hazin R, Barazi MK, Summerfield M. Challenges to establishing nationwide diabetic retinopathy screening programs. Curr Opin Ophthalmol. 2011;22(3):174-179.
16. Owsley C, McGwin G Jr, Lee DJ, et al; Innovative Network for Sight (INSIGHT) Research Group. Diabetes eye screening in urban settings serving minority populations: detection of diabetic retinopathy and other ocular findings using telemedicine. JAMA Ophthalmol. 2015;133(2):174-181.
17. Boyle JP, Honeycutt AA, Narayan KM, Hoerger TJ, Geiss LS, Chen H, Thompson TJ. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care. 2001;24(11):1936-40.
18. Saaddine JB, Honeycutt AA, Narayan KM, Zhang X, Klein R, Boyle JP. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 20052050. Arch Ophthalmol. 2008;126(12): 1740-1747.
19. Shi L, Wu H, Dong J, Jiang K, Lu X, Shi J. Telemedicine for detecting diabetic retinopathy: a systematic review and meta-analysis. Br J Ophthalmol. 2015;99(6):823-831.
20. Kirkizlar E, Serban N, Sisson JA, Swann JL, Barnes CS, Williams MD. Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration. Ophthalmology. 2013;120(12):2604-2610.
21. Cavallerano J, Zimmer-Galler I, Tennant M, et al; American Telemedicine Association Diabetic Retinopathy Telehealth Practice Recommendations Working Group. Telehealth practice recommendations for diabetic retinopathy, second edition. Telemed J E Health. 2011;17(10):814-837.
22. Wilkinson CP, Ferris FL III, Klein RE, et al; Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677-1682.
23. Tye A, Wharton H, Wright A, et al. Evaluating digital diabetic retinopathy screening in people aged 90 years and over. Eye (Lond). 2015;29(11):1442-1445.
24. Olafsdottir E, Andersson DK, Dedorsson I, Stefánsson E. The prevalence of retinopathy in subjects with and without type 2 diabetes mellitus. Acta Ophthalmol. 2014;92(2):133-137.
25. Jee D, Lee WK, Kang S. Prevalence and risk factors for diabetic retinopathy: the Korea National Health and Nutrition Examination Survey 20082011. Invest Ophthalmol Vis Sci. 2013;54(10): 6827-6833.
26. Rodriguez-Poncelas A, Miravet-Jiménez S, Casellas A, Barrot-De La Puente JF, Franch-Nadal J, López-Simarro F, Mata-Cases M, Mundet-Tudurí X. Prevalence of diabetic retinopathy in individuals with type 2 diabetes who had recorded diabetic retinopathy from retinal photographs in Catalonia (Spain). Br J Ophthalmol. 2015;99(12):1628-33.
27. Kostev K, Jockwig A, Hallwachs A, Rathmann W. Prevalence and risk factors of neuropathy in newly diagnosed type 2 diabetes in primary care practices: a retrospective database analysis in Germany and U.K. Prim Care Diabetes. 2014;8(3): 250-255.
28. Looker HC, Nyangoma SO, Cromie D, et al; Scottish Diabetic Retinopathy Screening Collaborative; Scottish Diabetes Research Network Epidemiology Group. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia. 2012;55(9): 2335-2342.
29. Kostev K, Rathmann W. Diabetic retinopathy at diagnosis of type 2 diabetes in the UK: a database analysis. Diabetologia. 2013;56(1):109-111.
30. Ding J, Wong TY. Current epidemiology of diabetic retinopathy and diabetic macular edema. Curr Diab Rep. 2012;12(4): 346-354.
31. Gregg EW, Li Y, Wang J, et al. Changes in diabetes-related complications in the United States, 19902010. N Engl J Med. 2014;370(16):1514-1523.